Sex differences in MAGEL2 gene promoter methylation in high functioning autism - trends from a pilot study using nanopore Cas9 targeted long read sequencing

Abstract Background MAGEL2 is an autism susceptibility gene whose deficiency has been associated with autism-related behaviors in animal models and in syndromic human autism spectrum disorders (ASDs) such as Schaaf-Yang syndrome, but has not been studied in the broader autism spectrum. Given the cap...

Full description

Saved in:
Bibliographic Details
Main Authors: Jelte Wieting, Kirsten Jahn, Stefan Bleich, Maximilian Deest, Helge Frieling
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Medical Genomics
Subjects:
Online Access:https://doi.org/10.1186/s12920-024-02053-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846147331908435968
author Jelte Wieting
Kirsten Jahn
Stefan Bleich
Maximilian Deest
Helge Frieling
author_facet Jelte Wieting
Kirsten Jahn
Stefan Bleich
Maximilian Deest
Helge Frieling
author_sort Jelte Wieting
collection DOAJ
description Abstract Background MAGEL2 is an autism susceptibility gene whose deficiency has been associated with autism-related behaviors in animal models and in syndromic human autism spectrum disorders (ASDs) such as Schaaf-Yang syndrome, but has not been studied in the broader autism spectrum. Given the capabilities of long-read sequencing technologies, this pilot study used a targeted nanopore sequencing approach to simultaneously examine MAGEL2 DNA sequence and methylation in adults with high-functioning autism (HFA) compared to neurotypical controls (NC). Methods Using DNA extracted from peripheral blood, Cas9-targeted nanopore DNA sequencing was used to analyze MAGEL2, including its entire regulatory construct (chr15:23639316–23651466), for sequence variation and 5-methyl-cytosine (5mC) modification in a cohort of adults with HFA compared to sex- and age-matched NC. Given the known sex differences in ASD and MAGEL2 KO animal models, results were further analyzed by sex. Results 20 adults with HFA (10 males, 10 females) and 20 NC were included. While there were no overall differences in MAGEL2 DNA sequence and 5mC modification between HFA and NC, we found a significant difference in MAGEL2 gene promoter methylation between males and females with HFA and NC of both sexes, with HFA males tending to show hypomethylation in a 300 bp long differentially methylated region (chr15:23647640–23647939) around the MAGEL2 transcription start site. Conclusions In this pilot study utilizing nanopore Cas9 targeted DNA sequencing, significant sex-specific differences in MAGEL2 gene promoter methylation were identified in male adults with HFA in comparison to control groups, suggesting the potential for sex-specific epigenetic differences. However, further replication in larger cohorts is required to validate these findings.
format Article
id doaj-art-113e4fb3a1fa4a4da54b2aaded1627e6
institution Kabale University
issn 1755-8794
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series BMC Medical Genomics
spelling doaj-art-113e4fb3a1fa4a4da54b2aaded1627e62024-12-01T12:49:10ZengBMCBMC Medical Genomics1755-87942024-11-0117111310.1186/s12920-024-02053-9Sex differences in MAGEL2 gene promoter methylation in high functioning autism - trends from a pilot study using nanopore Cas9 targeted long read sequencingJelte Wieting0Kirsten Jahn1Stefan Bleich2Maximilian Deest3Helge Frieling4Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical SchoolLaboratory for Molecular NeuroscienceDepartment of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical SchoolDepartment of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical SchoolDepartment of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical SchoolAbstract Background MAGEL2 is an autism susceptibility gene whose deficiency has been associated with autism-related behaviors in animal models and in syndromic human autism spectrum disorders (ASDs) such as Schaaf-Yang syndrome, but has not been studied in the broader autism spectrum. Given the capabilities of long-read sequencing technologies, this pilot study used a targeted nanopore sequencing approach to simultaneously examine MAGEL2 DNA sequence and methylation in adults with high-functioning autism (HFA) compared to neurotypical controls (NC). Methods Using DNA extracted from peripheral blood, Cas9-targeted nanopore DNA sequencing was used to analyze MAGEL2, including its entire regulatory construct (chr15:23639316–23651466), for sequence variation and 5-methyl-cytosine (5mC) modification in a cohort of adults with HFA compared to sex- and age-matched NC. Given the known sex differences in ASD and MAGEL2 KO animal models, results were further analyzed by sex. Results 20 adults with HFA (10 males, 10 females) and 20 NC were included. While there were no overall differences in MAGEL2 DNA sequence and 5mC modification between HFA and NC, we found a significant difference in MAGEL2 gene promoter methylation between males and females with HFA and NC of both sexes, with HFA males tending to show hypomethylation in a 300 bp long differentially methylated region (chr15:23647640–23647939) around the MAGEL2 transcription start site. Conclusions In this pilot study utilizing nanopore Cas9 targeted DNA sequencing, significant sex-specific differences in MAGEL2 gene promoter methylation were identified in male adults with HFA in comparison to control groups, suggesting the potential for sex-specific epigenetic differences. However, further replication in larger cohorts is required to validate these findings.https://doi.org/10.1186/s12920-024-02053-9MAGEL2High-functioning autismAutism spectrum disorderAdultSex differencesLong read sequencing
spellingShingle Jelte Wieting
Kirsten Jahn
Stefan Bleich
Maximilian Deest
Helge Frieling
Sex differences in MAGEL2 gene promoter methylation in high functioning autism - trends from a pilot study using nanopore Cas9 targeted long read sequencing
BMC Medical Genomics
MAGEL2
High-functioning autism
Autism spectrum disorder
Adult
Sex differences
Long read sequencing
title Sex differences in MAGEL2 gene promoter methylation in high functioning autism - trends from a pilot study using nanopore Cas9 targeted long read sequencing
title_full Sex differences in MAGEL2 gene promoter methylation in high functioning autism - trends from a pilot study using nanopore Cas9 targeted long read sequencing
title_fullStr Sex differences in MAGEL2 gene promoter methylation in high functioning autism - trends from a pilot study using nanopore Cas9 targeted long read sequencing
title_full_unstemmed Sex differences in MAGEL2 gene promoter methylation in high functioning autism - trends from a pilot study using nanopore Cas9 targeted long read sequencing
title_short Sex differences in MAGEL2 gene promoter methylation in high functioning autism - trends from a pilot study using nanopore Cas9 targeted long read sequencing
title_sort sex differences in magel2 gene promoter methylation in high functioning autism trends from a pilot study using nanopore cas9 targeted long read sequencing
topic MAGEL2
High-functioning autism
Autism spectrum disorder
Adult
Sex differences
Long read sequencing
url https://doi.org/10.1186/s12920-024-02053-9
work_keys_str_mv AT jeltewieting sexdifferencesinmagel2genepromotermethylationinhighfunctioningautismtrendsfromapilotstudyusingnanoporecas9targetedlongreadsequencing
AT kirstenjahn sexdifferencesinmagel2genepromotermethylationinhighfunctioningautismtrendsfromapilotstudyusingnanoporecas9targetedlongreadsequencing
AT stefanbleich sexdifferencesinmagel2genepromotermethylationinhighfunctioningautismtrendsfromapilotstudyusingnanoporecas9targetedlongreadsequencing
AT maximiliandeest sexdifferencesinmagel2genepromotermethylationinhighfunctioningautismtrendsfromapilotstudyusingnanoporecas9targetedlongreadsequencing
AT helgefrieling sexdifferencesinmagel2genepromotermethylationinhighfunctioningautismtrendsfromapilotstudyusingnanoporecas9targetedlongreadsequencing